This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma or Stage IV Adult Soft Tissue Sarcoma
and you are
over 18
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This phase II trial studies how well pazopanib hydrochloride works in treating patients with advanced angiosarcoma. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Provided treatments

  • Drug: pazopanib hydrochloride
  • Other: laboratory biomarker analysis
  • Procedure: positron emission tomography
  • Procedure: computed tomography
  • Radiation: fludeoxyglucose F 18

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01462630. The sponsor of the trial is Fox Chase Cancer Center and it is looking for 30 volunteers for the current phase.
Official trial title:
Phase II Study Evaluating the Role of Pazopanib in Angiosarcoma